XLO · CIK 0001840233 · operating
Xilio Therapeutics, Inc. (XLO) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $40 million, Xilio Therapeutics, Inc. is a micro-cap company. The stock currently trades at $0.56, up 5.68% today, with a 52-week range of $0.50–$1.18.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.09 | $-1.09 | +60.8% | |
| 2023 | $-2.78 | $-2.78 | +13.7% | |
| 2022 | $-3.22 | $-3.22 | +76.2% | |
| 2021 | $-13.52 | $-13.52 | — |